Results 121 to 130 of about 5,452,648 (239)

A Multicenter, Prospective Real‐World Study of Simethicone–Activated Charcoal in Patients With Persistent Dyspeptic Symptoms Despite Acid Suppression (SIMAC Study)

JGH Open, Volume 10, Issue 10, October 2026.
ABSTRACT Background Persistent gas‐predominant dyspeptic symptoms affect many patients despite adequate proton pump inhibitor (PPI) therapy, reflecting mechanisms beyond acid secretion. We evaluated the real‐world effectiveness and safety of simethicone (80 mg) plus activated charcoal (250 mg) in adults with persistent symptoms despite prior PPI ...
Ashish Kumar, D. V. Sreenivas, Sambit Kumar Behera, Guduru Raghavendra Srinivas Rao, G. S. Sameer Kumar, Jaya Ghosh Chatterjee, Nalini Kant Choudhary, Ravi Shankar Bagepally, Shekhar Puri, S. M. A. Rizvi, Rahul Pathak, Shruti Pal   +11 more
wiley   +1 more source

Dyspepsia, functional dyspepsia and Rome IV criteria

Revista Española de Enfermedades Digestivas, 2018
We present a number of comments about the recently published paper by Aziz et al. about the epidemiology of Functional Dyspepsia in USA, Canada and UK in comparison with previous studies in our country.
Caballero-Mateos, Antonio M ª, Redondo Cerezo, Eduardo   +1 more
openaire   +3 more sources

Halitosis and Helicobacter pylori Infection: A Systematic Review and Meta‐Analysis

JGH Open, Volume 10, Issue 10, October 2026.
ABSTRACT Background Halitosis, a common clinical condition, is frequently associated with Helicobacter pylori infection. Numerous studies have highlighted a significant reduction in halitosis following successful H. pylori eradication. Aim This meta‐analysis aimed to investigate the association between H.
Yu Xia, Jun‐Da Zhu, Tong Su, Bing‐Jie Jin, Shu‐Lei Zhao, Hong‐Wei Xu, Chang‐Qin Xu   +6 more
wiley   +1 more source

Dietary management and feeding considerations of pediatric aerodigestive and upper gastrointestinal motility disorders

Journal of Pediatric Gastroenterology and Nutrition, Volume 83, Issue 4, Page 748-760, October 2026.
Abstract Objective Pediatric aerodigestive and upper gastrointestinal (UGI) motility disorders are common and may be associated with compromised nutritional status and decreased quality of life. Traditional dietary recommendations for aerodigestive and UGI motility disorders have been rudimentary and largely based upon experience and common sense ...
Khalil El‐Chammas, Kirsten B. Jones, Joan Arvedson, Mary Boruta, Erick Toro‐Monjaraz, Anita Sicolo, Anil Darbari, Rachel Rosen, Julie Khlevner   +8 more
wiley   +1 more source

Screening evaluation of the depressive symptoms in children with combined functional dyspepsia and irritable bowel syndrome

Journal of V. N. Karazin Kharkiv National University: Series Medicine
Background. The course of combined functional dyspepsia and irritable bowel syndrome is characterized by more pronounced clinical symptoms and a deterioration in the quality of life.
Bielousova O.Yu., Shevchenko N.S., Zimnytska T.V., Kazarian L.V., Krutenko N.V.   +4 more
doaj   +1 more source

Mucosal‐Associated Invariant T Cells in Health and Disease

MedComm, Volume 7, Issue 10, October 2026.
The roles of MAIT cells in health and disease and their therapeutic applications. In healthy individuals, riboflavin metabolites secreted by commensal bacteria at mucosal sites are presented by MR1, leading to the activation of MAIT cells. Activated MAIT cells can maintain the barrier integrity of mucosal tissues in a steady state or migrate to the ...
Yu Zhao, Feng‐Mi Ou, Dan Liang, Yang Gao, Qing‐Qing Li, Yi‐Qun Kuang   +5 more
wiley   +1 more source

Gastrointestinal adverse effects of GLP‐1 receptor agonists and dual GIP/GLP‐1 receptor agonists: A narrative expert review of approved therapies, oral formulations, and pipeline agents

Nutrition in Clinical Practice, Volume 41, Issue 5, Page 1318-1333, October 2026.
Abstract Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and dual glucose‐dependent insulinotropic polypeptide (GIP)/GLP‐1 receptor agonists have transformed the management of type 2 diabetes and obesity. Gastrointestinal (GI) adverse events are the most common limitation of these therapies and a leading cause of discontinuation ...
Vikash Singhani, Muhammad Ehsan, Sara Valencia, Ahmed Nadeem, Eisha Moazzam, Winfield Scott Butsch, Samita Garg   +6 more
wiley   +1 more source

Systematic Review and Meta‐Analysis: Plant‐Based Therapy for Irritable Bowel Syndrome

Phytotherapy Research, Volume 40, Issue 10, Page 5918-5950, October 2026.
ABSTRACT Irritable bowel syndrome (IBS) is a common disorder of brain‐gut interaction that presents with abdominal pain, bloating associated with variable stool consistency. Many IBS patients prefer plant‐based preparations to pharmacological therapy; however, the utility of this approach is not well established.
Anselm Meyer, Jonas Auer, Lorena Cascant‐Ortolano, Niclas Schreiber, Amy Zimmermann‐Klemd, Carsten Gründemann, Philipp Busche, Jörg Schirra, Mark R. Fox   +8 more
wiley   +1 more source

Comparison of Some Personality Traits of Patients with Functional Dyspepsia and Healthy Individuals

Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, 2013
BACKGROUND AND OBJECTIVE: Functional dyspepsia is one of the most upper gastrointestinal disorders that affect the life quality of patients and medical expenses.
M Faramarzi, M Kashiferd, J Shokri-Shirvani   +2 more
doaj  

Functional Dyspepsia in Review: Pathophysiology and Challenges in the Diagnosis and Management due to Coexisting Gastroesophageal Reflux Disease and Irritable Bowel Syndrome

Gastroenterology Research and Practice, 2013
Functional dyspepsia is a common disorder which imposes significant diagnostic and treatment challenges for patients and physicians. The most recent update of the diagnostic criteria subdivides functional dyspepsia into two subcategories based on the ...
Shadi S. Yarandi, Jennifer Christie
doaj   +1 more source